期刊
BIOSENSORS & BIOELECTRONICS
卷 38, 期 1, 页码 389-395出版社
ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2012.06.040
关键词
Tumor cells; Drug resistance; Integrin beta 1; Enzyme electrode; Electrochemical immunoassay
类别
资金
- National Natural Science Foundation of China [20905025, 21145001, 20975037]
- Scientific Research Fund of Hunan Provincial Education Department [09B062]
- Program for Excellent Talents in Hunan Normal University [ET12203]
- Aid program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province
An electrochemical indirect competitive immunoassay protocol as a promising cytosensing strategy was developed to detect integrin beta 1 expression on human breast cancer MCF-7 cells and adriamycin-resistant human breast cancer MCF-7 (MCF-7/ADR) cells and quantify the cell number. Integrin alpha 5 beta 1 was adsorbed on the gold-nanoparticle modified glassy carbon electrode to bind integrin beta 1 monoclonal antibody (anti-CD29 mAb). A sandwich structure was then formed using nanocomposites which consisted of horseradish peroxidase (HRP) labeled anti-antibody and gold nanoparticles. HRP bound on the electrode surface could cause an amperometric response of the hydroquinone-H2O2 system. The assembly of the sandwich structure was inhibited by tumor cells to give decreased enzyme-catalytic signals due to the capture of anti-CD29 mAb by integrin beta 1 on cell membranes. Under optimal conditions the relative current change (S) was proportional to the cell concentration from 1.6 x 10(3) to 2.0 x 10(6) cells mL(-1) with a detection limit of 700 cells mL(-1). Integrin beta 1 expression in MCF-7/ADR cells was found to be significantly higher than that in MCF-7 cells, indicating the increased adhesion ability of MCF-7/ADR cells. (C) 2012 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据